Results 321 to 330 of about 3,462,732 (382)
Some of the next articles are maybe not open access.

Antineoplastic Agents, 88. Pimelea prostrata

Journal of Natural Products, 1983
The aerial portion of Pimelea prostrata (Thymelaeaceae) collected in New Zealand was evaluated as a source of substances that inhibit growth of the murine P-388 lymphocytic leukemia (PS). Simplexin (1) and Pimelea factor P2 (2) were found to strongly inhibit growth (ED50 5 X 10(-3) and 8 X 10(-4) micrograms/ml, respectively) of the PS in vitro cell ...
G R, Pettit   +4 more
openaire   +2 more sources

New Antineoplastic Agents

1989
New antineoplastic agents are being developed predominantly in industrial laboratories and only to a limited extent in university and other research institutes. The results of so-called screening assays, as conducted especially by the National Cancer Institute, have been disappointing in particular since the testing of many hundreds or thousands of ...
D. Schmähl   +3 more
openaire   +1 more source

Antineoplastic Agents

2023
Harold L. Kirschenbaum   +1 more
openaire   +1 more source

Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study

Supportive Care in Cancer, 2019
Sung Hwan Kim   +4 more
semanticscholar   +1 more source

Next Generation Antineoplastic Agents: A Review on Structurally Modified Vinblastine (VBL) Analogues.

Current Medicinal Chemistry, 2018
Ashanul Haque   +3 more
semanticscholar   +1 more source

Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents

Journal of Oncology Pharmacy Practice, 2018
G. Middendorff   +3 more
semanticscholar   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Home - About - Disclaimer - Privacy